Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells

International Journal of Cancer

Volumn 76, Issue 4, 1998, Pages 523-530

  Kihara Negishi, Fumiko ^a   Yamada, Toshiyuki ^a   Kubota, Yoshiko ^a   Kondoh, Nobuo ^a   Yamamoto, Hitomi ^a   Abe, Musaaki ^b   Shirai, Toshikazu ^b   Hashimoto, Yoshiyuki ^a   Oikawa, Tsuneyuki ^a,c  

^a SASAKI INSTITUTE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Cell Genetics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, MYC; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; PROTO-ONCOGENE PROTEINS; TIME FACTORS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0031980869     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980518)76:4<523::AID-IJC14>3.0.CO;2-8     Document Type: Article

References (22)

1. BEN-DAVID, Y. and BERNSTEIN, A., Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell, 66, 831-834 (1991).
2. L. Blood. 87, 3837-3842 (1996).
3. GOTTSCHALK, A.R., BOISE, L.H., THOMPSON, C.G. and QUINTÁS, J., Identification of immunosuppressant induced apoptosis in a murine B-cell line and its prevention by bc1-X but not bc1-2. Proc. nat Acad. Sci. (Wash.), 91, 7350-7354 (1994).
4. KIMURA, S., MAEKAWA, T., HIRAKAWA, K., MURAKAMI, A. and ABE, T., Alteration of c-myc expression by antisense oligodeoxynucleotides enhances the induction of apoptosis in HL-60 cells. Cancer Res., 55, 1379-1384 (1995).
5. KLEMZ, M., MCKERCHER, S.R., CELADA, A., VAN BEVERN, C. and MAKI, R.A., The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell, 61, 113-124 (1990).
6. KOURY, M. and BONDURANT, M.C., Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science, 248, 378-381 (1990).
7. LACHAMAN, H.M. and SKOULTCHI, A.I., Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature (Lond.), 310, 592-594 (1984).
8. LIEBERMAN, D.A., HOFFMAN, B. and STEINMAN, R.A., Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways, Oncogene, 11, 199-210 (1995).
9. MARKES, P.A., RICHON, V.M. and RIFKIND, R.A., Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: molecular and clinical studies employing hybrid polar compounds. Int. J. Hematol., 63, 1-17 (1996).
10. MCKERCHER, S.R., TORBETT, B.E., ANDERSON, K.L., HENKEL, G.W., VESTAL, D.J., BARIBAUT, H., KLEMZ, M., FEENEY, A.J., WU, G.E., PAIGE, C.J. and MAKI, R.A., Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J., 15, 5647-5658 (1996).
11. MOREAU-GACHELIN, F., Spi-l/PU.1: an oncogene of the Ets family. Biochim. biophys. Acta. 1198, 149-163 (1994).
12. NELSEN, B., TIAN. G., ERMAN, B., GERGOIRE, J., MAKI, R., GRAVES, B. and SEN, R., Regulation of lymphoid-spccific immunoglohulin μ heavy chain gene enhancer by Ets-domain proteins. Science, 261, 82-86 (1993).
13. PACKHAM, G. and CLEVELAND, J.L., c-Myc and apoptosis. Biochem. biophys. Acta, 1242, 11-28 (1995).
14. RYAN, J.J., DANISH, R., GOTTLIEB, C.A. and CLARKE, M.F., Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. cell. Biol., 13, 711-719 (1993).
15. SIMON, M.C., OLSON, M., SCOTT, E., HACK, A., SU, G. and SINGH, H., Terminal myeloid gene expression and differentiation requires transcription factor PU.1. Curr. Topics Microbiol. Immunol., 211, 113-119 (1996).
16. THOMPSON, C.B., Apoptosis in pathogenesis and treatment of disease. Science. 267, 1456-1462 (1995).
17. THULASI, R., HARBOUR, D.V. and THOMPSON, E.B., Suppression of c-myc is a critical step in glucocorticoid-induced human leukemie cell lysis. J. biol. Chem., 268, 18306-18312 (1993).
18. WASYLYK, B., HANN, S.L. and GIOVANE, A., The Ets family of transcription factors. Europ. J. Biochem., 211, 7-18 (1993).
19. WHITE, E., Death-defying acts: a meeting review on apoptosis. Genes Develop., 7, 2277-2284 (1993).
20. YAMADA, T., KONDOH, N., MATSUMOTO, M., YOSHIDA, M., MAEKAWA, A. and OIKAWA, T., Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood, 89, 1383-1393 (1997).
21. YANG, E. and KORSMEYER, S.J., Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood, 88, 386-401 (1996).
22. ZHANG, D.-E., HETHERINGTON, C.J., CHEN, H.-M. and TENEN, D.G., The macrophage transcription factor PU.l directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol. cell. Biol., 14, 373-381 (1994).